Tag: Stomach acid-withstanding peptide pills could be a new type of oral drug

Stomach acid-withstanding peptide pills could be a new type of oral drug

May 14, 2020

Researchers at the Swiss Federal Institute of Technology Lausanne (EPFL) have recently developed a novel method of testing and creating peptides that can survive degradation by stomach acids – these could potentially make up oral drugs for chronic inflammatory diseases of the gastrointestinal (GI) tract, unlike current medications that must be injected or administered in […]

Continue Reading